Who
Richard Newcomb Stillwell
Director
Company insider
Files Form 4 as: Director, Tonix Pharmaceuticals Holding.
In numbers
- Trades disclosed
- 8
- Buys
- 1
- Sells
- 0
- Bought
- $117K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 15 Mar 2023
- Last trade
- 8 Jun 2026
- Last filed
- 9 Jun 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jun 2026filed 9 Jun 2026 | TNXP Tonix Pharmaceuticals HoldingBiotechnology | SEC FORM 4 Bought | $58K5,000 at $11.65 | filing |
| 8 Jun 2026filed 9 Jun 2026 | TNXP Tonix Pharmaceuticals HoldingBiotechnology | SEC FORM 4 Bought | $58K5,000 at $11.65 | filing |
| 12 May 2026filed 14 May 2026 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,700 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,700 at $0.00 | filing |
| 13 May 2025filed 15 May 2025 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 23 May 2024filed 24 May 2024 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —104,621 at $0.00 | filing |
| 8 May 2023filed 10 May 2023 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 15 Mar 2023filed 16 Mar 2023 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —83,000 at $0.00 | filing |
News
Tonix Pharmaceuticals Sets 2027 Phase 1 Target For TNX-801 Vaccine CandidateTNXP · rttnews.com · 15 Oct 2026Tonix Pharmaceuticals Begins Building Lyme Disease Drug Facility in Hamilton, MontanaTNXP · matr.net · 12 Oct 2026
0 headlines in the last 90 days name Richard Newcomb Stillwell; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.